Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

Clinical trial NCT02632903 · WITHDRAWN

Trial details

NCT number: NCT02632903
Sponsor: Children's Hospital of Eastern Ontario
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Osteoporosis Osteonecrosis Acute Lymphoblastic Leukemia

Start date: 2016-10-01
Primary completion: 2018-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.